{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:47:01Z","timestamp":1768322821451,"version":"3.49.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1U19GH000571-01"],"award-info":[{"award-number":["1U19GH000571-01"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["MRC-RFA-UFSP-01-2013\/UKZN HIVEPI"],"award-info":[{"award-number":["MRC-RFA-UFSP-01-2013\/UKZN HIVEPI"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.1093\/jac\/dkx252","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T11:16:27Z","timestamp":1501586187000},"page":"3141-3148","source":"Crossref","is-referenced-by-count":24,"title":["Rates of virological suppression and drug resistance in adult HIV-1-positive patients attending primary healthcare facilities in KwaZulu-Natal, South Africa"],"prefix":"10.1093","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8933-0628","authenticated-orcid":false,"given":"Gillian M","family":"Hunt","sequence":"first","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa"},{"name":"Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Kainne","family":"Dokubo","sequence":"additional","affiliation":[{"name":"Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simbarashe","family":"Takuva","sequence":"additional","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa"},{"name":"Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulio","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa"},{"name":"Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Ledwaba","sequence":"additional","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nomathemba","family":"Dube","sequence":"additional","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pravi","family":"Moodley","sequence":"additional","affiliation":[{"name":"Department of Virology, National Health Laboratory Services\/University of KwaZulu-Natal, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Sabatier","sequence":"additional","affiliation":[{"name":"Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varough","family":"Deyde","sequence":"additional","affiliation":[{"name":"US Centers for Disease Control and Prevention, Pretoria, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Morris","sequence":"additional","affiliation":[{"name":"Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa"},{"name":"Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Raizes","sequence":"additional","affiliation":[{"name":"Division of Global HIV and TB, US Centers for Disease Control and Prevention, Atlanta, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"key":"key\n\t\t\t\t20180328154402_dkx252-B1","author":"UNAIDS"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B2","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B3","author":"World Health Organization","year":"2014"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B4","author":"Shisana","year":"2014"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B5"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B6"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B7","year":"2015"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B8","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/jmv.22143","article-title":"Resistance to antiretroviral drugs in newly diagnosed, young treatment-naive HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa","volume":"83","author":"Parboosing","year":"2011","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1089\/aid.2011.0284","article-title":"Primary drug resistance in South Africa: data from 10\u2009years of surveys","volume":"28","author":"Manasa","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B10","doi-asserted-by":"crossref","first-page":"S334","DOI":"10.1093\/cid\/cir1017","article-title":"Surveillance of transmitted HIV-1 drug resistance in the Gauteng and KwaZula-Natal regions of South Africa from 2005-2009","volume":"54","author":"Hunt","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B11","doi-asserted-by":"crossref","first-page":"e59787.","DOI":"10.1371\/journal.pone.0059787","article-title":"Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009)","volume":"8","author":"Parikh","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B12","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/aid.2015.0225","article-title":"Increasing HIV-1 drug resistance between 2010 and 2012 in adults participating in population-based HIV surveillance in rural KwaZulu-Natal, South Africa","volume":"32","author":"Manasa","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B13","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1086\/587109","article-title":"Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa","volume":"46","author":"Marconi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B14","doi-asserted-by":"crossref","first-page":"e72152.","DOI":"10.1371\/journal.pone.0072152","article-title":"High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa","volume":"8","author":"Manasa","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B15","doi-asserted-by":"crossref","first-page":"299.","DOI":"10.4172\/2155-6113.1000299","article-title":"HIV drug resistance patterns at the epicentre of the HIV-1 epidemic in Kwazulu-Natal, South Africa 2003-2013","volume":"5","author":"Kiepiela","year":"2014","journal-title":"J AIDS Clin Res"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/135965350801302S09","article-title":"Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004","volume":"13","author":"Pillay","year":"2008","journal-title":"Antivir Ther"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B17","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/bioinformatics\/btt162","article-title":"RegaDB: community-driven data management and analysis for infectious diseases","volume":"29","author":"Libin","year":"2013","journal-title":"Bioinformatics"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B18","author":"The South African Antiretroviral Treatment Guidelines","year":"2010"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B19","author":"The South African Antiretroviral Treatment Guidelines","year":"2013"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B20","author":"World Health Organization"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B21","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1097\/QAD.0b013e328356886d","article-title":"High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen","volume":"26","author":"Sunpath","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B22","doi-asserted-by":"crossref","first-page":"e67188.","DOI":"10.1371\/journal.pone.0067188","article-title":"Trends in genotypic HIV-1 antiretroviral resistance between 2006 and 2012 in South African patients receiving first- and second-line antiretroviral treatment regimens","volume":"8","author":"Van Zyl","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B23","doi-asserted-by":"crossref","first-page":"e0118145.","DOI":"10.1371\/journal.pone.0118145","article-title":"High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa","volume":"10","author":"Skhosana","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(15)00536-8","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study","volume":"16","author":"The TenoRes Study Group","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B25","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1097\/01.aids.0000232228.88511.0b","article-title":"HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture","volume":"20","author":"Brenner","year":"2006","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B26","doi-asserted-by":"crossref","first-page":"14.","DOI":"10.1186\/1742-4690-6-14","article-title":"Effects of the K65R and K65R\/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance","volume":"6","author":"Xu","year":"2009","journal-title":"Retrovirology"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B27","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/QAD.0b013e3281ac229b","article-title":"Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase","volume":"21","author":"Parikh","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2471\/BLT.12.112946","article-title":"Viral suppression after 12\u2009months of antiretroviral therapy in low- and middle-income countries: a systematic review","volume":"91","author":"McMahon","year":"2013","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.15585\/mmwr.mm6446a3","article-title":"Scale-up of HIV viral load monitoring\u2014seven sub-Saharan African countries","volume":"64","author":"Lecher","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180328154402_dkx252-B30","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cid\/civ556","article-title":"Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low- and middle-income countries: a systematic review and meta-analysis","volume":"61","author":"Boender","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/11\/3141\/21359253\/dkx252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T17:55:23Z","timestamp":1659290123000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/72\/11\/3141\/4061566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,8,3]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx252","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,8,3]]}}}